Fulgent Genetics Inc Equity-NMS: FLGT

Healthcare

Diagnostics & Research

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$20.61

Open :

$20.68

Today's high :

$21.16

Today's low :

$20.48

52W low :

$14.57

52W high :

$24

EPS(TTM): :

-1.66

Shares O/S :

30.61 M

Market cap :

649.83 M

What is the share price of Fulgent Genetics Inc today?

Fulgent Genetics Inc (FLGT) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Fulgent Genetics Inc?

Yes, Indian Investors can invest in the Fulgent Genetics Inc (FLGT) Share by opening an international trading account with Angel One.

How can I purchase Fulgent Genetics Inc shares in India?

Purchasing Fulgent Genetics Inc (FLGT) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Fulgent Genetics Inc (FLGT) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Fulgent Genetics Inc?

Yes, you can purchase fractional shares of Fulgent Genetics Inc (FLGT) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Fulgent Genetics Inc?

The market capitalization of Fulgent Genetics Inc on January 1, 1970, is $0.

What documents are required to invest in Fulgent Genetics Inc stocks?

In order to invest in Fulgent Genetics Inc (FLGT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Fulgent Genetics, Inc. is a technology-based company with a laboratory services business and a therapeutic development business. Its laboratory services business includes technical laboratory and testing services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a novel nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. Its testing services include comprehensive anatomic pathology testing services, including gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology, and precision diagnostics testing services, including next-generation sequencing (NGS), tests for biopharma research and clinical tests for rare disease, hereditary cancer, reproductive health, and many other diseases.